Warren Hosseinion - 19 Mar 2026 Form 4 Insider Report for Nutex Health Inc. (NUTX)

Reporting relationship: President, Director
Issuer ticker: NUTX
Reported as of: 19 Mar 2026
Net transaction value: +$23,706
SEC form: 4
Accepted by SEC: 23 Mar 2026, 13:21:13 UTC
Prior SEC filing: 11 Mar 2026
Next SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Warren Hosseinion

Key filing fact

Warren Hosseinion filed Form 4 for Nutex Health Inc. (NUTX) on 23 Mar 2026.

Key facts

This page summarizes Warren Hosseinion's Form 4 filing for Nutex Health Inc. (NUTX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Mar 2026, 13:21.

Change

Previous filing in this sequence was filed on 11 Mar 2026.
Current net transaction value: +$23,706.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001438327 Primary reporting owner

Hosseinion Warren

Relationship: President, Director
Address: 1776 YORKTOWN STREET, C/O NUTEX HEALTH INC., HOUSTON
Signature: /s/ Warren Hosseinion
Signature date: 23 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Purchase

Transaction value: $23,706
Shares: +252
Change %: +3.4%
Price: $94.07
Shares after: 7,765
Date: 19 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUTX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: +3,656
Change %: +42%
Price: $0.000000^*
Shares after: 12,465
Date: 10 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,656
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.